171 related articles for article (PubMed ID: 16652140)
1. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.
Dunne J; Cullmann C; Ritter M; Soria NM; Drescher B; Debernardi S; Skoulakis S; Hartmann O; Krause M; Krauter J; Neubauer A; Young BD; Heidenreich O
Oncogene; 2006 Oct; 25(45):6067-78. PubMed ID: 16652140
[TBL] [Abstract][Full Text] [Related]
2. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells.
Heidenreich O; Krauter J; Riehle H; Hadwiger P; John M; Heil G; Vornlocher HP; Nordheim A
Blood; 2003 Apr; 101(8):3157-63. PubMed ID: 12480707
[TBL] [Abstract][Full Text] [Related]
3. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
[TBL] [Abstract][Full Text] [Related]
4. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients.
Krauter J; Wattjes MP; Nagel S; Heidenreich O; Krug U; Kafert S; Bunjes D; Bergmann L; Ganser A; Heil G
Br J Haematol; 1999 Oct; 107(1):80-5. PubMed ID: 10520027
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF.
Shimada H; Ichikawa H; Nakamura S; Katsu R; Iwasa M; Kitabayashi I; Ohki M
Blood; 2000 Jul; 96(2):655-63. PubMed ID: 10887131
[TBL] [Abstract][Full Text] [Related]
6. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.
Miyoshi H; Kozu T; Shimizu K; Enomoto K; Maseki N; Kaneko Y; Kamada N; Ohki M
EMBO J; 1993 Jul; 12(7):2715-21. PubMed ID: 8334990
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
8. In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21).
Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
Biochimie; 1996; 78(11-12):1067-73. PubMed ID: 9150886
[TBL] [Abstract][Full Text] [Related]
9. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis.
Shimada H; Ichikawa H; Ohki M
Leukemia; 2002 May; 16(5):874-85. PubMed ID: 11986950
[TBL] [Abstract][Full Text] [Related]
10. Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia.
Kondo M; Kudo K; Kimura H; Inaba J; Kato K; Kojima S; Matsuyama T; Horibe K
Leuk Res; 2000 Nov; 24(11):951-6. PubMed ID: 11086178
[TBL] [Abstract][Full Text] [Related]
11. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon.
Shimizu K; Kitabayashi I; Kamada N; Abe T; Maseki N; Suzukawa K; Ohki M
Blood; 2000 Jul; 96(1):288-96. PubMed ID: 10891464
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21).
Tobal K; Yin JA
Blood; 1996 Nov; 88(10):3704-9. PubMed ID: 8916934
[TBL] [Abstract][Full Text] [Related]
13. Induction of MTG8-specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AML1-MTG8-fused gene-positive acute myelogenous leukaemia.
Maeda M; Otsuka T; Kimura N; Kozu T; Fukuyama T; Uchida N; Sugio Y; Itoh Y; Iino T; Inaba S; Niho Y
Br J Haematol; 2000 Nov; 111(2):570-9. PubMed ID: 11122105
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.
Berg T; Fliegauf M; Burger J; Staege MS; Liu S; Martinez N; Heidenreich O; Burdach S; Haferlach T; Werner MH; Lübbert M
Haematologica; 2008 Nov; 93(11):1728-33. PubMed ID: 18790797
[TBL] [Abstract][Full Text] [Related]
15. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
Liu S; Shen T; Huynh L; Klisovic MI; Rush LJ; Ford JL; Yu J; Becknell B; Li Y; Liu C; Vukosavljevic T; Whitman SP; Chang KS; Byrd JC; Perrotti D; Plass C; Marcucci G
Cancer Res; 2005 Feb; 65(4):1277-84. PubMed ID: 15735013
[TBL] [Abstract][Full Text] [Related]
16. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission.
Satake N; Maseki N; Kozu T; Sakashita A; Kobayashi H; Sakurai M; Ohki M; Kaneko Y
Br J Haematol; 1995 Dec; 91(4):892-8. PubMed ID: 8547135
[TBL] [Abstract][Full Text] [Related]
17. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
18. UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.
Fukuyama T; Kitamura T; Kozu T
Int J Hematol; 2022 May; 115(5):686-693. PubMed ID: 35152350
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.
Sakakura C; Yamaguchi-Iwai Y; Satake M; Bae SC; Takahashi A; Ogawa E; Hagiwara A; Takahashi T; Murakami A; Makino K
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11723-7. PubMed ID: 7972130
[TBL] [Abstract][Full Text] [Related]
20. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
